NMT-A004

N/A

Report date: 2025/06/11 10:37:53
NME

Base Information

Drug NameNMT-A004
Drug Alias Nameantileishmanial dinitroaniline-ether phospholipid hybrids (Universidade do Porto/Fraunhofer Institute for Molecular Biology and Applied Ecology)NMT-A004NMT-A0011
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLeishmaniasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPortugalGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversidade do Porto
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsLeishmaniasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A